Published in J Gastroenterol Hepatol on October 01, 2001
Peribiliary cysts: a hitherto poorly recognized disease. J Gastroenterol Hepatol (2001) 0.86
A case of peribiliary cysts accompanying bile duct carcinoma. World J Gastroenterol (2006) 0.84
Peribiliary hepatic cysts presenting as hilar cholangiocarcinoma in a patient with end-stage liver disease. J Surg Case Rep (2016) 0.75
Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers. Dig Dis Sci (2016) 0.75
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract (1995) 12.51
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol (1992) 5.93
Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nat Genet (1992) 4.69
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Array-based genomic resequencing of human leukemia. Oncogene (2010) 3.77
Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell (1995) 3.64
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia (2003) 2.80
Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med (1990) 2.72
Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol (1979) 2.56
Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol (1994) 2.41
Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med (1994) 2.38
Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet (1990) 2.35
Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol (1990) 2.30
Chemistry and biochemistry of metallothionein. Experientia Suppl (1987) 2.29
Application of a reverse transcription-PCR for identification and differentiation of Aichi virus, a new member of the Picornavirus family associated with gastroenteritis in humans. J Clin Microbiol (2000) 2.19
Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol (1994) 2.05
Amino-acid sequence of equine renal metallothionein-1B. Proc Natl Acad Sci U S A (1976) 1.99
Effect of forest bathing on physiological and psychological responses in young Japanese male subjects. Public Health (2011) 1.88
Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol (1998) 1.82
Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology (1992) 1.81
Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76
Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother (1998) 1.76
Endoscopic ultrasound-guided fine-needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy (2006) 1.74
Studies on pyrocatechase. I. Purification and spectral properties. J Biol Chem (1967) 1.70
The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol (1995) 1.64
Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med (1995) 1.63
Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res (1999) 1.63
Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb (1994) 1.63
Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab (2004) 1.62
A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61
Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut (1999) 1.60
Analyses of ornithine decarboxylase antizyme mRNA with a cDNA cloned from rat liver. J Biochem (1990) 1.57
Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diabetes Care (2000) 1.55
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol (1984) 1.55
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology (1999) 1.54
The effects of exercise in forest and urban environments on sympathetic nervous activity of normal young adults. J Int Med Res (2006) 1.49
Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C. J Gastroenterol (1998) 1.49
Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody. J Virol (1991) 1.48
Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol (1998) 1.47
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem (1985) 1.47
The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology (1992) 1.46
A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse. Br J Haematol (1993) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol (1995) 1.45
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. Br J Cancer (2011) 1.44
Case report: portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt. J Gastroenterol Hepatol (1996) 1.43
Immediate interlocking nailing versus external fixation followed by delayed interlocking nailing for Gustilo type IIIB open tibial fractures. J Orthop Surg (Hong Kong) (2007) 1.42
Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura. Intern Med (2000) 1.42
STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int J Cancer (1998) 1.41
Congenital anomalies of the kidney and urinary tract--role of the loss of function mutation in the pluripotent angiotensin type 2 receptor gene. J Urol (2001) 1.41
White coat hypertension in two adolescents. Pediatr Nephrol (1999) 1.41
Salinomycin, a new polyether antibiotic. J Antibiot (Tokyo) (1974) 1.40
Serum pepsinogen I levels and acid secretion in Helicobacter pylori associated enlarged fold gastritis. Ital J Gastroenterol (1997) 1.40
Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol (1999) 1.40
Antihemophilic factor release by perfused liver and spleen: relationship to hemophilia. Science (1967) 1.40
Forward cardiac output measurement with first-pass technique using 99mTc-labeled myocardial perfusion imaging agents. J Nucl Med (1999) 1.38
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J (2004) 1.37
Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities. Eur J Biochem (1984) 1.37
Response to interferon of GB virus C and hepatitis C virus in patients with chronic hepatitis. Am J Gastroenterol (1997) 1.37
Phylogenetic study of methanogens associated with rumen ciliates. Curr Microbiol (1999) 1.37
Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation (1991) 1.36
Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2007) 1.34
Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med (1997) 1.33
Destabilization of ornithine decarboxylase by transfected antizyme gene expression in hepatoma tissue culture cells. J Biol Chem (1992) 1.32
Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest (1999) 1.30
Regions of the lipopolysaccharide of Pseudomonas aeruginosa essential for antitumor and interferon-inducing activities. Eur J Biochem (1979) 1.29
Antizyme, a protein induced by polyamines, accelerates the degradation of ornithine decarboxylase in Chinese-hamster ovary-cell extracts. Biochem J (1992) 1.28
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest (1995) 1.27
Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology (1991) 1.26
Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut (1996) 1.26
Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol (1994) 1.25
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus. Clin Pharmacol Ther (2007) 1.25
Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology (1992) 1.24
Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice. Antimicrob Agents Chemother (2000) 1.23
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia (2003) 1.22
Salinomycin: a new monovalent cation ionophore. Biochem Biophys Res Commun (1975) 1.22
The pathogenesis of carbon monoxide encephalopathy in the acute phase--physiological and morphological correlation. Acta Neuropathol (1981) 1.22
Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem Biophys Res Commun (1990) 1.21
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia (2010) 1.19
Studies on monooxygenases. I. General properties of crystalline L-lysine monooxygenase. J Biol Chem (1969) 1.18
Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17
Nucleotide sequence of the Clostridium stercorarium xynA gene encoding xylanase A: identification of catalytic and cellulose binding domains. Biosci Biotechnol Biochem (1993) 1.17
Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2001) 1.17
A malignant granular cell tumor of the stomach: report of a case. Surg Today (1996) 1.17
Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol (1999) 1.16
Necropsy findings in HTLV-I associated myelopathy. Lancet (1987) 1.16
Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Jpn J Exp Med (1990) 1.13
Lymphangioma of the transverse colon treated by transendoscopic polypectomy: report of a case and review of literature. Dis Colon Rectum (1981) 1.13
A new antibiotic CJ-17,665 from Aspergillus ochraceus. J Antibiot (Tokyo) (2001) 1.13
High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas. Eur J Immunol (1997) 1.12
Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol (1994) 1.11
High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens (1997) 1.10
Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest (1991) 1.10
Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line. J Urol (1998) 1.10
Mutations of the bak gene in human gastric and colorectal cancers. Cancer Res (2000) 1.10
Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis (1995) 1.09
Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut (1994) 1.09
Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob Agents Chemother (2000) 1.09